Skip to main content

Schizoaffective Disorder clinical trials at UCSD
3 in progress, 1 open to new patients

  • Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia

    open to eligible people ages 18-50

    This application seeks to determine if neurophysiological metrics of memantine (MEM)-enhanced early auditory information processing (EAIP) in schizophrenia (SZ) mediate gains in auditory processing fidelity (APF) and auditory learning.

    San Diego, California

  • Mobile CBT for Negative Symptoms

    Sorry, not yet accepting patients

    This randomized controlled clinical trial will test a combined group contact plus mobile CBT-informed skills training intervention targeting defeatist attitudes in consumers with schizophrenia in comparison to a supportive contact control group in order to change motivational negative symptoms linked to defeatist attitudes.

  • Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia

    Sorry, in progress, not accepting new patients

    This clinical trial will test a combined group therapy plus mobile cognitive behavioral therapy intervention targeting defeatist attitudes in consumers with schizophrenia in order to change motivational negative symptoms linked to defeatist attitudes.

Last updated: